University of Rochester Medicine Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 82
• Ovarian cancer diagnosis and treatment 70
• PARP inhibition in cancer therapy 20
• Uterine Myomas and Treatments 17
• Cervical Cancer and HPV Research 11
• Ectopic Pregnancy Diagnosis and Management 11
• Colorectal Cancer Surgical Treatments 10
• Chemotherapy-induced cardiotoxicity and mitigation 9
• Cancer survivorship and care 8
• Gestational Trophoblastic Disease Studies 8
• Angiogenesis and VEGF in Cancer 7
• Frailty in Older Adults 7

Most cited

1. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Richard Moore

2. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 148 citations · Richard Moore

3. Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 336 citations · Lyndsay Willmott

4. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

   Nature medicine · 2025 · 59 citations · Richard Moore

5. First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 53 citations · Richard Moore

6. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.